Neurogene (NGNE) Return on Capital Employed Growth (5y) (2019 - 2026)
Neurogene (NGNE) Return on Capital Employed Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Neurogene | 771.78 Mn | 771.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,298.00 |
| Dec 31, 2025 | -2,182.00 |
| Sep 30, 2025 | -1,806.00 |
| Jun 30, 2025 | 2,780.00 |
| Mar 31, 2025 | 2,475.00 |
| Dec 31, 2024 | 3,581.00 |
| Sep 30, 2024 | 6,769.00 |
| Jun 30, 2024 | -1,463.00 |
| Dec 31, 2023 | 222.00 |
| Sep 30, 2023 | -1,251.00 |
| Jun 30, 2023 | -969.00 |
| Dec 31, 2022 | -231.00 |
| Sep 30, 2022 | -1,407.00 |
| Jun 30, 2022 | -1,446.00 |
| Mar 31, 2022 | -1,730.00 |
| Sep 30, 2021 | -834.00 |
| Jun 30, 2021 | 533.00 |
| Mar 31, 2021 | 97.00 |
| Dec 31, 2020 | 350.00 |
| Sep 30, 2020 | 1,767.00 |